# A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma

> **NCT02512900** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 21 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MEDI9929, 140 mg

## Key facts

- **NCT ID:** NCT02512900
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-10
- **Primary completion:** 2016-05-17
- **Final completion:** 2016-05-17
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02512900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02512900, "A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02512900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*